Second, some might dismiss these statements as blame shifting. Given it was often the same policymakers that disrupted supply chains in the medical goods and medicines sector once the coronavirus spread by resorting to over 200 export controls, there may be something to this. The wrinkle with this argument is that the Japanese government which did not impose any export bans has also joined the critique of cross-border supply chains and is financially supporting Japanese firms that move production facilities out of China.
Third, analysts may decide to critically evaluate the policymakers’ critique. That was the purpose of a large part of my paper and, by any reasonable standard of logic and evidence, the case made against cross-border supply chains is unconvincing. No objective standard by which cross-border supply chains were to be judged was enunciated by policymakers, although thinking through what such a standard should be in the context of a pandemic is worthwhile. In extremis, how should cross-border supply chains be judged?